Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
TLPHthis companyTalphera, Inc.	$1.07	-3.35×	2.84×	1,726.72×	-3.41×	-102.6%	100.0%	-48157.1%	-51035.7%	-83.9%	-52.0%	-23.5%	0.38×	-0.04×	0×	5.49×	0.0%	3	-23.57	1	D+
APUSApimeds Pharmaceuticals US, Inc	$2.61	-2.98×	0.12×	0×	-4.2×	-321.0%	0.0%	0.0%	0.0%	-3.9%	-7.4%	-50.3%	0.05×	-1.07×	-42.09×	1.31×	0.0%	1	-2.08	2	C+
IBIOiBio, Inc.	$0.82	-5.47×	2.12×	1,821.05×	-4×	-38.6%	100.0%	-35141.0%	-33044.0%	-38.6%	-40.0%	-13.1%	0.03×	1.7×	-663.04×	7.85×	0.0%	2	-3.05	2	C+
INTSIntensity Therapeutics, Inc.	$3.20	-1.2×	1.17×	0×	-0.18×	143.3%	0.0%	0.0%	0.0%	-97.7%	-99.9%	-66.3%	0.01×	1.02×	0×	5.92×	0.0%	2	-10.06	3	B
MIRAMIRA Pharmaceuticals, Inc.	$0.62	-1.12×	3.44×	0×	-2.82×	-51.0%	0.0%	0.0%	0.0%	-100.5%	-101.0%	-13.0%	0×	0.61×	0×	15.75×	0.0%	2	320.98	1	C-
NTRBNutriband Inc.	$5.89	-1.86×	8.35×	27.38×	-6.42×	-123.8%	27.8%	-408.4%	-404.1%	-123.2%	-120.1%	-9.2%	0.04×	0.54×	-369.11×	6.36×	0.0%	3	34.78	1	C-
Peer median	—	-1.86×	2.12×	0×	-4×	-51.0%	0.0%	0.0%	0.0%	-97.7%	-99.9%	-13.1%	0.03×	0.61×	-42.09×	6.36×	0.0%	2	-2.08	2	—